Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab + Trastuzumab +/- Metronomic Chemo in Elderly HER2+ MBC
NCT01597414Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jun 2013
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of pertuzumab in breast cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Jun 2013; status: completed.
02
Drugs
pertuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01597414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597414.